MCRB
Price
$15.96
Change
+$0.78 (+5.14%)
Updated
Jan 16 closing price
Capitalization
144.38M
Intraday BUY SELL Signals
OTLK
Price
$0.55
Change
+$0.03 (+5.77%)
Updated
Jan 16 closing price
Capitalization
35.02M
Intraday BUY SELL Signals
Interact to see
Advertisement

MCRB vs OTLK

Header iconMCRB vs OTLK Comparison
Open Charts MCRB vs OTLKBanner chart's image
Seres Therapeutics
Price$15.96
Change+$0.78 (+5.14%)
Volume$46K
Capitalization144.38M
Outlook Therapeutics
Price$0.55
Change+$0.03 (+5.77%)
Volume$2.05M
Capitalization35.02M
MCRB vs OTLK Comparison Chart in %
MCRB
Daily Signal:
Gain/Loss:
OTLK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MCRB vs. OTLK commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and OTLK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (MCRB: $15.96 vs. OTLK: $0.55)
Brand notoriety: MCRB and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 26% vs. OTLK: 23%
Market capitalization -- MCRB: $144.38M vs. OTLK: $35.02M
MCRB [@Biotechnology] is valued at $144.38M. OTLK’s [@Biotechnology] market capitalization is $35.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 1 FA rating(s) are green whileOTLK’s FA Score has 1 green FA rating(s).

  • MCRB’s FA Score: 1 green, 4 red.
  • OTLK’s FA Score: 1 green, 4 red.
According to our system of comparison, MCRB is a better buy in the long-term than OTLK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 3 TA indicator(s) are bullish while OTLK’s TA Score has 5 bullish TA indicator(s).

  • MCRB’s TA Score: 3 bullish, 4 bearish.
  • OTLK’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а +1.98% price change this week, while OTLK (@Biotechnology) price change was -7.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($144M) has a higher market cap than OTLK($35M). MCRB has higher P/E ratio than OTLK: MCRB (18.14) vs OTLK (0.59). MCRB YTD gains are higher at: 7.258 vs. OTLK (-65.430). OTLK has higher annual earnings (EBITDA): -42.64M vs. MCRB (-103.62M). MCRB has more cash in the bank: 47.6M vs. OTLK (8.9M). OTLK has less debt than MCRB: OTLK (34.7M) vs MCRB (85.3M). OTLK has higher revenues than MCRB: OTLK (1.51M) vs MCRB (0).
MCRBOTLKMCRB / OTLK
Capitalization144M35M411%
EBITDA-103.62M-42.64M243%
Gain YTD7.258-65.430-11%
P/E Ratio18.140.593,053%
Revenue01.51M-
Total Cash47.6M8.9M535%
Total Debt85.3M34.7M246%
FUNDAMENTALS RATINGS
MCRB vs OTLK: Fundamental Ratings
MCRB
OTLK
OUTLOOK RATING
1..100
2450
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
52100
PRICE GROWTH RATING
1..100
5698
P/E GROWTH RATING
1..100
2618
SEASONALITY SCORE
1..100
1475

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (68) in the Biotechnology industry is in the same range as OTLK (77). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's SMR Rating (52) in the Biotechnology industry is somewhat better than the same rating for OTLK (100). This means that MCRB’s stock grew somewhat faster than OTLK’s over the last 12 months.

MCRB's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for OTLK (98). This means that MCRB’s stock grew somewhat faster than OTLK’s over the last 12 months.

OTLK's P/E Growth Rating (18) in the Biotechnology industry is in the same range as MCRB (26). This means that OTLK’s stock grew similarly to MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBOTLK
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 28 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MCRB
Daily Signal:
Gain/Loss:
OTLK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFVF54.755.70
+11.62%
Alfa-Laval AB
CWBHF0.380.02
+5.81%
Charlotte's Web Holdings Inc.
IRME0.04N/A
N/A
IR-Med Inc.
PSKRY95.05N/A
N/A
Protector Forsikring ASA
PMETF4.54-0.24
-5.04%
PMET Resources Inc.

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+5.14%
ORMP - MCRB
42%
Loosely correlated
+6.98%
AXON - MCRB
38%
Loosely correlated
-0.18%
AMRN - MCRB
36%
Loosely correlated
-0.81%
ARRY - MCRB
34%
Loosely correlated
-2.83%
TAOX - MCRB
34%
Loosely correlated
-1.10%
More

OTLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with CYTK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+4.60%
CYTK - OTLK
33%
Loosely correlated
-1.35%
PDSB - OTLK
33%
Loosely correlated
+0.70%
MCRB - OTLK
32%
Poorly correlated
+5.14%
VIR - OTLK
31%
Poorly correlated
-2.26%
ALXO - OTLK
30%
Poorly correlated
-3.31%
More